Troponin elevation in conditions other than acute coronary syndromes
- PMID: 22102783
- PMCID: PMC3212425
- DOI: 10.2147/VHRM.S24509
Troponin elevation in conditions other than acute coronary syndromes
Abstract
Acute coronary syndromes comprise a large spectrum of clinical conditions ranging from unstable angina pectoris to acute ST-elevation myocardial infarction. Chest pain is usually the major symptom of atherosclerotic heart disease; however, it may be challenging to diagnose correctly, especially in the emergency department, because of the ambiguous way that pain is characterized by some patients. Cardiac troponins are sensitive and specific biomarkers used in the diagnosis of myocardial infarction that are released into the bloodstream when cardiac myocytes are damaged by acute ischemia or any other mechanism. They are the cornerstone for the diagnosis, risk assessment, prognosis, and determination of antithrombotic and revascularization strategies. However, troponin elevation indicates the presence, not the mechanism, of myocardial injury. There are many clinical conditions other than myocardial infarction that cause troponin elevation; thus, the physician should be aware of the wide spectrum of disease states that may result in troponin elevation and have a clear understanding of the related pathophysiology to effectively make a differential diagnosis. This review focuses on causes of troponin elevation other than acute coronary syndromes.
Keywords: cardiac troponin; differential diagnosis; troponin elevation without acute coronary syndrome.
Similar articles
-
Diagnostic performance of high sensitive troponin in non-ST elevation acute coronary syndrome.Med Intensiva (Engl Ed). 2020 Mar;44(2):88-95. doi: 10.1016/j.medin.2018.07.014. Epub 2018 Sep 21. Med Intensiva (Engl Ed). 2020. PMID: 30249382 English, Spanish.
-
Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study.Heart Lung Circ. 2017 Oct;26(10):1051-1058. doi: 10.1016/j.hlc.2016.11.018. Epub 2016 Dec 31. Heart Lung Circ. 2017. PMID: 28139353
-
Troponin elevation in other conditions than acute coronary syndromes.Ann Biol Clin (Paris). 2017 Aug 1;75(4):411-419. doi: 10.1684/abc.2017.1262. Ann Biol Clin (Paris). 2017. PMID: 28751286 English.
-
Cardiac troponin level elevations not related to acute coronary syndromes.Nat Rev Cardiol. 2013 Nov;10(11):623-34. doi: 10.1038/nrcardio.2013.129. Epub 2013 Aug 27. Nat Rev Cardiol. 2013. PMID: 23979214 Review.
-
[Management of acute coronary syndrome without ST-segment elevation].Herz. 2017 Apr;42(2):211-228. doi: 10.1007/s00059-017-4541-x. Herz. 2017. PMID: 28233037 Review. German.
Cited by
-
Diagnostic Performance of Coronary Tomography Angiography and Serial Measurements of Sensitive Cardiac Troponin in Patients With Chest Pain and Intermediate Risk for Cardiovascular Events.Arq Bras Cardiol. 2022 May;118(5):894-902. doi: 10.36660/abc.20210006. Arq Bras Cardiol. 2022. PMID: 35137790 Free PMC article. English, Portuguese.
-
[Effect of co-morbid chronic kidney disease on the accuracy of cardiac troponin levels for diagnosis of acute myocardial infarction].Nan Fang Yi Ke Da Xue Xue Bao. 2023 Feb 20;43(2):300-307. doi: 10.12122/j.issn.1673-4254.2023.02.20. Nan Fang Yi Ke Da Xue Xue Bao. 2023. PMID: 36946052 Free PMC article. Chinese.
-
Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis.Biomedicines. 2025 Jan 14;13(1):193. doi: 10.3390/biomedicines13010193. Biomedicines. 2025. PMID: 39857776 Free PMC article.
-
Utility of Cardiac Troponin to Predict Drug Overdose Mortality.Cardiovasc Toxicol. 2016 Oct;16(4):355-60. doi: 10.1007/s12012-015-9345-8. Cardiovasc Toxicol. 2016. PMID: 26541348 Free PMC article.
-
Significance of detecting cardiac troponin I and creatine kinase MB in critically Ill children without primary cardiac illness.Front Pediatr. 2024 Sep 2;12:1445651. doi: 10.3389/fped.2024.1445651. eCollection 2024. Front Pediatr. 2024. PMID: 39286452 Free PMC article.
References
-
- Lippi G, Targher G, Franchini M, Plebani M. Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. Clin Chem Lab Med. 2009;47(10):1183–1194. - PubMed
-
- Thygesen K, Alpert JS, White HD, et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525–2538. - PubMed
-
- Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858–867. - PubMed
-
- Christenson RH, Phillips D. Sensitive and high sensitivity next generation cardiac troponin assays: more than just a name. Pathology. 2011;43(3):213–219. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources